Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-08
2008-01-08
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S411000, C548S466000, C206S569000, C206S570000
Reexamination Certificate
active
11175824
ABSTRACT:
Pyrrole-oxindole derivatives useful as progesterone receptor antagonists, and methods for preparing the same, are provided. Pharmaceutical compositions containing these derivatives are described, as is the use thereof in contraception and hormone-related conditions.
REFERENCES:
patent: 5585378 (1996-12-01), Boar et al.
patent: 6391907 (2002-05-01), Fensome et al.
patent: 6407101 (2002-06-01), Collins et al.
patent: 6444668 (2002-09-01), Grubb et al.
patent: 6462032 (2002-10-01), Grubb et al.
patent: 6503937 (2003-01-01), Nesvadba et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6544970 (2003-04-01), Grubb et al.
patent: 6562857 (2003-05-01), Collins et al.
patent: 6566358 (2003-05-01), Zhang et al.
patent: 6608068 (2003-08-01), Fensome et al.
patent: 6436929 (2004-03-01), Zhang et al.
patent: 6713478 (2004-03-01), Zhang et al.
patent: 6759408 (2004-07-01), Grubb et al.
patent: 7084168 (2006-08-01), Fensome et al.
patent: 2002/0128208 (2002-09-01), Snyder et al.
patent: 2003/0092711 (2003-05-01), Zhang et al.
patent: 2003/0158182 (2003-08-01), Collins et al.
patent: 2003/0216432 (2003-11-01), Pfahl et al.
patent: 2004/0002535 (2004-01-01), Fensome et al.
patent: 2004/0006122 (2004-01-01), Fensome et al.
patent: 2004/0034004 (2004-02-01), Pfahl et al.
patent: 2004/0142933 (2004-07-01), Forest et al.
patent: 2004/0152719 (2004-08-01), He et al.
patent: 2004/0152755 (2004-08-01), He et al.
patent: 2004/0186101 (2004-09-01), Zhang et al.
patent: 2005/0227971 (2005-10-01), Wilk et al.
patent: 2005/0228178 (2005-10-01), Lerestif et al.
patent: 2005/0250766 (2005-11-01), Wilk et al.
patent: 2005/0256110 (2005-11-01), Collins et al.
patent: 2005/0261327 (2005-11-01), Bock et al.
patent: 2005/0272702 (2005-12-01), Wilk et al.
patent: 2006/0030615 (2006-02-01), Fensome et al.
patent: 2006/0142348 (2006-06-01), Singh et al.
patent: 2006/0160882 (2006-07-01), Fensome et al.
patent: WO-94/29272 (1994-12-01), None
patent: WO 00/66556 (2000-11-01), None
patent: WO 00/66581 (2000-11-01), None
patent: WO 200066167 (2000-11-01), None
patent: WO-03/082265 (2003-10-01), None
patent: WO-20040937247 (2004-05-01), None
Winneker et al., “Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships”, Seminars in Reproductive Medicine, 23(1): 46 (Feb. 2005).
Collins et al., “Novel Pyrrole-Containing Progesterone Receptor Modulators”, Bioorganic & Medicinal Chemistry Letters, 14: 2185 (May 3, 2004).
Fensome et al., “New Progesterone Receptor Antagonists: 3,3-Disubstituted-5-aryloxindoles”, Bioorganic & Medicinal Chemistry Letters, 12: 3487 (Dec. 2, 2002).
Allan et al., “Non-steroidal Progesterone Receptor Specific Ligands”, Mini-Reviews in Medicinal Chemistry, 5:701 (Aug. 2005).
Fensome et al., “Novel 5-aryl-1,3-dihydro-indole-2-thiones: Potent, Orally Active Progesterone Receptor Agonists”, Bioorg. & Med. Chem. Lett., 13(7):1317-1320 (Apr. 7, 2003).
Jiang et al., “Design, Synthesis & Biological Evaluation of Novel Oxindoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Part I”, Bioorg. & Med. Chem. Lett., 16(8):2105-2108 (Feb. 9, 2006).
Terefenko et al., “SAR Studies of 6-Aryl-1,3-dihydrobenzimidazol-2-ones as Progesterone Receptor Antagonists” Bioorg. & Med. Chem. Lett., 15(15):3600-3603 (Jun. 22, 2005).
Fensome Andrew
Grubb Gary Sondermann
Marella Michael Anthony
McComas Casey Cameron
Melenski Edward George
Anderson Rebecca
Barker Michael P.
Howson & Howson LLP
Milowsky Arnold S.
Wyeth
LandOfFree
Progesterone receptor modulators comprising pyrrole-oxindole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Progesterone receptor modulators comprising pyrrole-oxindole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progesterone receptor modulators comprising pyrrole-oxindole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3914761